Zynex Nexwave Singapore - English - HSA (Health Sciences Authority)

zynex nexwave

bmec pte ltd - general hospital - the nexwave is a multifunction two-channel, multi-waveform combo electrotherapy device with various treatment modes that allow for neuromuscular electrical stimulation (nmes), transcutaneous electrical nerve stimulator (tens) and interferential current stimulation (if). interferential mode (ifc) *muscle re-education *prevention of retardation of disuse atrophy *increasing local blood circulation *maintaining or increasing range of motion *relaxation of muscle spasms *post-surgical stimulation of calf muscles to prevent deep venous thrombosis as a nmes device, the nexwave device is indicated for the following conditions: *muscle re-education *prevention of retardation of disuse atrophy *increasing local blood circulation *maintaining or increasing range of motion *relaxation of muscle spasms as a tens device, the nexwave device is indicated for the following conditions: *management and symptomatic relief of chronic intractable pain, post traumatic and post-surgical pain

NEXWAR 10 TAB India - English - Central Drugs Standard Control Organization

nexwar 10 tab

nexus - paracetamol,chlorpheniramine maleate,phenylpropanolamine hcl.,caffeine - tab - 500,2,12.5,30;mg - 10

SANDAWHA VITAMIN C BRIGHTENING ESSENCE- ascorbyl glucoside liquid United States - English - NLM (National Library of Medicine)

sandawha vitamin c brightening essence- ascorbyl glucoside liquid

skincure inc - ascorbyl glucoside (unii: 2v52r0nhxw) (ascorbyl glucoside - unii:2v52r0nhxw) - remove the appearance of dark spots and prevent unwanted skin pigmentation apply liberal amount on your face. for the best results use twice daily in the morning and the evening.

Ibuprofen 100mg/5ml Oral Suspension United Kingdom - English - myHealthbox

ibuprofen 100mg/5ml oral suspension

actavis group ptc ehf - ibuprofen - oral suspension - 100mg/5ml - anti-inflammatory and antirheumatic products, non-steroids; propionic acid derivative - children 3 months to 12 years (> 5 kg): • the reduction of fever, including post immunisation pyrexia • the relief of the symptoms of colds and influenza • the relief of mild to moderate pain, such as a sore throat, teething pain, toothache, earache, headache, minor aches and sprains.

SAFLUTAN 15 micrograms/ml eye drops, solution, in single-dose container United Kingdom - English - myHealthbox

saflutan 15 micrograms/ml eye drops, solution, in single-dose container

santen oy - tafluprost - eye drops, solution in single-dose container - 15 micrograms - antiglaucoma preparations and miotics, prostaglandin analogues - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension. as adjunctive therapy to beta-blockers

JUBLIA- efinaconazole solution United States - English - NLM (National Library of Medicine)

jublia- efinaconazole solution

bausch health us llc - efinaconazole (unii: j82sb7fxwb) (efinaconazole - unii:j82sb7fxwb) - efinaconazole 100 mg in 1 ml - jublia (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to trichophyton rubrum and trichophyton mentagrophytes . none. risk summary there are no available human data for the use of jublia during pregnancy to inform any drug associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, efinaconazole did not cause malformations or any harm to the fetus when administered to pregnant rabbits and rats during the period of organogenesis at subcutaneous doses up to 112 and 154 times, respectively, the maximum recommended human dose (mrhd) based on area under the curve (auc) comparisons. embryolethality was observed only in rats in the presence of maternal toxicity at systemic exposures 559 times the mrhd based on auc comparisons. subcutaneous efinaconazole administration to pregnant rats from the beginning of organogenesis through the end of lactation did not cause em

ANUBISMED- glycolic acid, citric acid, lactic acid, kojic acid liquid United States - English - NLM (National Library of Medicine)

anubismed- glycolic acid, citric acid, lactic acid, kojic acid liquid

anubis cosmetics sl - glycolic acid (unii: 0wt12sx38s) (glycolic acid - unii:0wt12sx38s), kojic acid (unii: 6k23f1tt52) (kojic acid - unii:6k23f1tt52), hexylresorcinol (unii: r9qtb5e82n) (hexylresorcinol - unii:r9qtb5e82n), ascorbyl glucoside (unii: 2v52r0nhxw) (ascorbyl glucoside - unii:2v52r0nhxw), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), phenoxyethanol (unii: hie492zz3t) (phenoxyethanol - unii:hie492zz3t), propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3), hydroxyethyl cell -